All
Search
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Is Ambry Genetics
Spam
Ambry Genetic
Testing
Ambry Genetic
Screening Protocols
Ambry Genetics
Loreli Jolliff
Brad Positivity
@ Ambracherry
Breast Stock
Cancer
Genetics
Ambry
Ambry
Genomic Science Liaison
Ptagm
EpCAM
504 Plan Familial Polyposis
Adipophilia
Genomics vs
Genetics Cancer
NextGENe Ce Drive
Familial Polyposis Cleveland Ohio
Hereditary Breast Cancer
Genetic
Tumor Syndrome
Genetic
Cancer Case Study
Hereditary Cancer Syndrome
Cancer Genetics
Basics
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Is Ambry Genetics
Spam
Ambry Genetic
Testing
Ambry Genetic
Screening Protocols
Ambry Genetics
Loreli Jolliff
Brad Positivity
@ Ambracherry
Breast Stock
Cancer
Genetics
Ambry
Ambry
Genomic Science Liaison
Ptagm
EpCAM
504 Plan Familial Polyposis
Adipophilia
Genomics vs
Genetics Cancer
NextGENe Ce Drive
Familial Polyposis Cleveland Ohio
Hereditary Breast Cancer
Genetic
Tumor Syndrome
Genetic
Cancer Case Study
Hereditary Cancer Syndrome
Cancer Genetics
Basics
3:01
Looking back at 2013, we asked former colleagues in the fight against gene patents to remember the historic ruling and reflect on how the industry has changed since and what might be next. Jenny Geurts, Certified Genetic Counselor, remembers the impact the SCOTUS ruling had on her patients and talks about the continued importance of striving toward health equity and best outcomes for patients. #KeepGenesFree | Ambry Genetics
44 views
Jun 15, 2023
Facebook
Ambry Genetics
0:46
Innovation has always been in our DNA. In the last 25 years, Ambry has been proud to lead the way as the first company to offer several major industry developments, including first to offer clinical exome in 2011, first to offer BRCA-testing after the Supreme Court decision in 2013, and first paired DNA/RNA testing for hereditary cancer in 2019. Check out the interactive timeline at https://hubs.ly/Q02QsylR0. #Ambry25 #SettingtheStandard #ExperienceMatters | Ambry Genetics
51 views
Sep 23, 2024
Facebook
Ambry Genetics
2:06
Ambry CEO Tom Schoenherr shares the importance of #RareDiseaseDay. #MoreThanYouCanImagine | Ambry Genetics
316 views
Feb 24, 2025
Facebook
Ambry Genetics
4:39
Emily Maxwell, MS, CGC, discusses a poster presented at #ACMG2025 that sought to determine if PMS2CL pseudogene interference in #PMS2 testing is more prevalent in Non-European populations and how follow-up can help eliminate ambiguities. #genetictesting | Ambry Genetics
99 views
Apr 14, 2025
Facebook
Ambry Genetics
2:11
Everyone at Ambry is here with a single goal in mind - helping patients. Learn how our Variant Assessment team is making a difference in patient care by bringing clarity to genetic testing results | Ambry Genetics
918 views
Sep 5, 2018
Facebook
Ambry Genetics
2:01
The R&D team is Ambry’s innovation hub, where the tests that will serve patients in the future are conceived. They are also responsible for the development and clinical validation of every task the clinical lab performs. Rachid Karam, VP of Research and Development, shared why he’s proud to work at Ambry and how the North Star of all our employees is the direct impact of everything we do and our commitment to positively impact people’s lives. #ASCPLabWeek24! #TheLabIsEverything #OneAmbry | Ambry
27 views
Apr 16, 2024
Facebook
Ambry Genetics
3:34
Ambry was ready to launch BRCA1 and BRCA2 testing on the day of the SCOTUS decision because we were invested in the idea that people have the right to this testing and that it should be accessible to all. Ambry has continued this philosophy by collaborating with labs all over the world to increase understanding of the human genome. Jessie Grzybowski, MS, LCGC, Sr. Medical Science Liaison-Oncology, shares a poignant story from the day of the SCOTUS ruling about the first BRCA-positive patient Amb
241 views
Jun 14, 2023
Facebook
Ambry Genetics
0:27
In April 2020, RNAinsight, the first paired DNA/RNA test for hereditary cancer, received an honorable mention in Fast Company’s 2020 World Changing Ideas Award, watch the full video at https://hubs.ly/H0yH2T30 | Ambry Genetics
71 views
Nov 3, 2020
Facebook
Ambry Genetics
0:48
The Ambry Classifi™️ Program is committed to providing the right answer, the first time. Our variant classification team leverages the best of both people and process to ensure an advanced scientific approach. Hear more from Dr. Rhonda Lassiter, leader of the Genomic Science Development Program at Ambry. Learn more: https://hubs.ly/Q02s4DKK0 | Ambry Genetics
46 views
Apr 11, 2024
Facebook
Ambry Genetics
1:41
Catherine Mayo, MS, CGC, joined us from #ACMG2025 to explore Sanger, MLPA and #RNA data on next-generation sequencing data to resolve clinical diagnoses with previously negative #genetictesting. #NGS | Ambry Genetics
80 views
Apr 11, 2025
Facebook
Ambry Genetics
1:00
Thank you to Ambry Genetics for sponsoring our San Antonio Breast Cancer Symposium series, we're grateful for your partnership. Ambry is a genetic testing lab, who also offers innovative digital solutions for identifying patients at increased risk for cancer, including the CARE Program. One of Ambry's CARE partners, Midstate Radiology Associates, is presenting at the San Antonio Breast Cancer Symposium and will showcase how CARE transformed their high-risk patient identification. | Sharsheret
102 views
Dec 10, 2024
Facebook
Sharsheret
3:29
Exome sequencing has historically been used for complex cases that remained undiagnosed after other testing methods were tried. Ambry Clinical Research Coordinator Brooklyn Gasser explores the effectiveness of guidelines that recommend first-tier exome testing for neurodevelopmental disorders versus other multi-gene panel tests. #exome #neuro #VUS | Ambry Genetics
76 views
Jan 14, 2025
Facebook
Ambry Genetics
1:06
Ambry CEO, Tom Schoenherr, has a personal message following the Comparably announcement naming us on the Best CEO and Best Company Culture lists. Both are based on anonymous ratings from our own employees. Interested in joining our incredible team? Visit our careers page: https://hubs.ly/Q0112Q0B0 #comparably #culture | Ambry Genetics
319 views
Dec 21, 2021
Facebook
Ambry Genetics
0:14
Ambry has been helping patients get access to testing with greater clarity by leveraging RNA since 2019. We are thrilled to announce that we have completed over 1,000,000 RNA analyses for patients! #DNAandRNA #BetterTogether #MoreAnswersforMorePatients Read the press release: https://hubs.ly/Q041jWjQ0 | Ambry Genetics
48 views
3 months ago
Facebook
Ambry Genetics
0:41
Join Jennifer Herrera-Mullar, MGC, CGC, DMA, as she explains what she loves about her role as a Principal Clinical Scientist on the Gene Team at Ambry Genetics and introduces the Gene of the Month, MSH3. Check out this short video and click here to learn more about Jeni and how mutations in MSH3 can affect patients on our blog: https://hubs.ly/Q01L04Wx0 You know your patients. #AmbryKnowsGenes. Partner with us to end diagnostic odysseys sooner and improve care for patients with rare diseases. |
109 views
Apr 11, 2023
Facebook
Ambry Genetics
36:06
Last week we opened our 65,000 square-foot Super Lab. This lab represents the success of Ambry’s mission & evolution. Thank you to all who came out to our grand opening! | Ambry Genetics
21 views
Feb 22, 2016
Facebook
Ambry Genetics
Tempus Completes Acquisition Of Ambry Genetics
Feb 3, 2025
marketscreener.com
Ambry Genetics | LinkedIn
Mar 10, 2011
linkedin.com
0:24
TBT: With the celebration of RNA Day in August, we're kicking it back to this old school Ambry video of the launch of RNAInsight® in 2019. More than five years later, this technology continues to analyze functional RNA data to help classify DNA variants. Patients continue to receive more accurate testing through lower inconclusive outcomes and higher diagnostic yield.. Ambry is proud to continue its legacy as the first to offer paired RNA and DNA testing. https://hubs.ly/Q03DR2H40 | Ambry Geneti
52 views
9 months ago
Facebook
Ambry Genetics
3:03
Margo Gallegos, MS, CGC, Genomic Science Liaison, was a genetic counseling student in 2013. She reflects on the rapid growth of genetic testing and how things have changed. Her experience shows that sometimes it seems like change is slow in coming, but looking back at notes she had taken in school, she can see how this decision created a whole new world of information. #KeepGenesFree | Ambry Genetics
68 views
Jun 16, 2023
Facebook
Ambry Genetics
3:45
Here at Ambry, we understand that families impacted by rare disease may experience loss, and that grief can be complicated when there isn't any explanation. We believe strongly in the power of information for families even after a loss. Jessica Gage, MS, CGC, shares a moving case study about how Patient for Life provided answers for a family five years after their son's birth. #exome #PatientforLife #genetictesting | Ambry Genetics
77 views
Jun 18, 2024
Facebook
Ambry Genetics
4:21
Terra Brennan, PhD, joined us from CGA-IGC to discuss the findings from Ambry's poster 009 in collaboration with Providence Health: "A novel missense variant in CDH1 causes hereditary diffuse gastric and lobular breast cancer syndrome independently of splicing." #CGAIGC23 #CDH1 #gastriccancer #breastcancer #DGLBC #genetictesting | Ambry Genetics
43 views
Oct 27, 2023
Facebook
Ambry Genetics
1:51
Ambry account executive Noelle Carbognin shared her family's story for #LynchSyndromeAwarenessDay. Watch the video and then read her blog to explore the importance of advocating for your health and how knowing your family history can lead to actionable knowledge and empowerment. #genetictesting #coloncancer #Lynchsydrome https://hubs.ly/Q03cVgjq0 🌊Dive deeper with these Ambry blogs: https://hubs.ly/Q03cVjr30 https://hubs.ly/Q03cVfg50 | Ambry Genetics
171 views
Mar 22, 2025
Facebook
Ambry Genetics
5:01
Margo Gallegos, MS, CGC explores a Patient for Life case and explains how Amby's proactive reanalysis made a difference for a five-year-old's family and how they received a more complete understanding of his clinical features, years after their original exome and after they switched providers. #exome #PatientforLife | Ambry Genetics
73 views
May 14, 2024
Facebook
Ambry Genetics
1:56
Jeni Herrera-Mullar MGC, CGC, DMA and Principal Clinical Scientist at Ambry Genetics shows why RPS20 is a bona fide, high penetrance gene for #colorectalcancer predisposition in this “Top 20” poster from #ACMG2025. This science and data, in combination with medical management guidelines, drove our latest hereditary cancer menu update. Some of our panels and base-panels now include RPS20. Learn more about these updates: https://hubs.ly/Q03j3W5Z0. | Ambry Genetics
61 views
Apr 24, 2025
Facebook
Ambry Genetics
0:53
"It takes a village to offer best-in-class service." Watch a special message from Ambry’s Chief Operating Officer Brigette Tippin Davis for Medical Laboratory Professionals Week and explore what makes Ambry so special. #ASCPLabWeek24! #TheLabIsEverything #OneAmbry | Ambry Genetics
108 views
Apr 12, 2024
Facebook
Ambry Genetics
2:20
Meet Matthew Do, Ambry AI/ML Summer Intern. | Ambry Genetics
50 views
8 months ago
Facebook
Ambry Genetics
3:51
Ambry doesn’t like to let patient diagnoses remain a mystery for long! Sam Apodaca shares how the Patient for Life™ program solved the mystery and ended the diagnostic odyssey for three families. #AnotherCaseSolved #MedicalLaboratoryProfessionalsWeek | Ambry Genetics
62 views
Apr 23, 2025
Facebook
Ambry Genetics
1:23
Don’t miss Ambry’s poster ASD15 at #NSGC2023 today, “Validation of patient-facing digital tool risk stratification of those at risk for hereditary cancer syndrome: The CARE program™ accurately identifies high risk individuals.” The purpose of this study was to assess the analytic validity of the CARE platform by determining the accuracy of the digital tool’s execution and interpretation of NCCN guidelines as compared to certified genetic counselor’s (CGC) interpretation of the same guidelines an
16 views
Oct 19, 2023
Facebook
Ambry Genetics
1:52
Ambry’s Translational Genomics Lab (ATG Lab) offers a unique lab service that can provide novel evidence to bring clarity to variants of unknown significance, so that clinicians have more information to guide patient care | Ambry Genetics
5.5K views
Sep 26, 2018
Facebook
Ambry Genetics
See more
More like this
Feedback